Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Protocol for Sub-Study of the ASCOT Trial
  • Published:

Protocol for Sub-study of the ASCOT Trial

Left ventricular hypertrophy and silent ischaemia: a pilot study to examine the relationship in hypertensive patients

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. De-Leeuw PW et alHypertension and the development of heart failure J Cardiovasc Pharmacol 1998 32 (Suppl 1) S9–S15

    Google Scholar 

  2. Opie LH et alThe multifarious spectrum of ischemic left ventricular dysfunction: relevance of new ischemic syndromes J Mol Cell Cardiol 1996 28 2403–2414

    Article  CAS  Google Scholar 

  3. Conlon PJ et alIncidence and long-term significance of transient ST segment deviation in hemodialysispatients Clin Nephrol 1998 49 236–239

    CAS  PubMed  Google Scholar 

  4. Kovacevic DV et alAsymptomatic myocardial ischemia before and after surgical revascularisation inpatients with multivessel occlusive coronary disease Med Pregl 1998 51 73–75

    CAS  PubMed  Google Scholar 

  5. Erne P et al Antiischemic therapy improves event free survival in silent ischemia type I. Results of the Swiss Interventional Study on Silent Ischemia I (SWISS1 I) 48th Annual Scientific Session, American College of Cardiology 1999

    Google Scholar 

  6. Mahgoub MA et alDiabetes mellitus and cardiac function Mel Cell Biochem 1998 80 59–64

    Article  Google Scholar 

  7. Beth J et alMetoprolol abolishes exercise induced left ventricular dysfunction inpatients with silent ischemia Am J Cardiol 1996 78 871–875

    Article  Google Scholar 

  8. Cohn PF Silent myocardial ischemia: to treat or not to treat? Hosp Pract Off Ed 1994 29 107–112, 115–116

    Google Scholar 

  9. Cohn PF Rationale for the use of calcium antagonists in the treatment of silent myocardial ischemia Clin Ther 1997 19 (Suppl A) 74–91

    Article  Google Scholar 

  10. Pepine CJ et alEffects of treatment on outcome in mildly symptomaticpatients with ischemia during daily life. The Atenolol Silent Ischemia Study (ASIST) Circulation 1994 90 762–768

    Article  CAS  Google Scholar 

  11. Davies RF et alEffect of atenolol, amlodipine and their combination on myocardial ischemia during treadmill exercise and ambulatory monitoring. Canadian Amlodipine/Atenolol in Silent Ischemia Study (CASIS) J Am Coil Cardiol 1995 25 619–625

    Article  CAS  Google Scholar 

  12. Volkov VI et alAsymptomatic myocardial ischemia in the dynamics of anaprilin and korinfar treatment Lik Sprava 1997 5 114–117

    Google Scholar 

  13. Asmar R et alPrevalence and circadian variations of ST-segment depression and its concomitant blood pressure changes in asymptomatic systemic hypertension Am J Cardiol 1996 77 384–390

    Article  CAS  Google Scholar 

  14. Devereux RB et alMeasurement of left ventricular mass: methodology and expertise J Hypertens 1997 15 801–809

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

O’Brien, E., Gribbin, C., Stanton, A. et al. Left ventricular hypertrophy and silent ischaemia: a pilot study to examine the relationship in hypertensive patients. J Hum Hypertens 15 (Suppl 1), S75–S77 (2001). https://doi.org/10.1038/sj.jhh.1001090

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jhh.1001090

Keywords

Search

Quick links